PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 116 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 4.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $556 | +79.9% | 1,866 | 0.0% | 0.00% | – |
Q2 2023 | $309 | -99.8% | 1,866 | -97.0% | 0.00% | – |
Q1 2021 | $162,000 | +3.2% | 62,904 | +0.2% | 0.00% | – |
Q4 2020 | $157,000 | +28.7% | 62,804 | +6.6% | 0.00% | – |
Q3 2020 | $122,000 | -41.6% | 58,904 | -12.7% | 0.00% | – |
Q2 2020 | $209,000 | +45.1% | 67,499 | +6.8% | 0.00% | – |
Q1 2020 | $144,000 | -37.1% | 63,189 | 0.0% | 0.00% | – |
Q4 2019 | $229,000 | +7.0% | 63,189 | +0.5% | 0.00% | – |
Q3 2019 | $214,000 | -28.2% | 62,886 | -0.7% | 0.00% | -100.0% |
Q2 2019 | $298,000 | +34.8% | 63,336 | -3.9% | 0.00% | – |
Q1 2019 | $221,000 | +24.2% | 65,934 | -1.3% | 0.00% | – |
Q4 2018 | $178,000 | -27.9% | 66,836 | +51.5% | 0.00% | – |
Q3 2018 | $247,000 | +2.5% | 44,116 | -7.1% | 0.00% | – |
Q2 2018 | $241,000 | +6.6% | 47,466 | +43.5% | 0.00% | – |
Q1 2018 | $226,000 | -1.7% | 33,074 | +8.7% | 0.00% | – |
Q4 2017 | $230,000 | +6.5% | 30,434 | -18.8% | 0.00% | – |
Q3 2017 | $216,000 | +17.4% | 37,464 | +3.2% | 0.00% | – |
Q2 2017 | $184,000 | – | 36,285 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
CM Management, LLC | 649,400 | $193,521 | 0.20% |
BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |